Skip to main content

Table 1 Patient characteristics (n = 50)

From: Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer

 

No. Patients (n = 50)

Age, median (range), yr

57 (32–80)

Follow-up period (m)

59.1 (2–120)

FIGO

 Stage I

25 (50%)

 Stage II

4 (8%)

 Stage III

12 (24%)

 Stage IV

9 (18%)

Histology

 High-grade serous

16 (30%)

 Endometrioid

12 (8%)

 Clear cell

22 (44%)

Dissemination and metastasis at diagnosis (overlapped, depending on the cases)

 Dissemination

18 (36%)

 Lymph node metastasis

12 (24%)

 Distant metastasis

3 (0.6%)

Recurrent site (overlapped, depending on the cases)

 Dissemination

17 (34%)

 Lymph node metastasis

10 (20%)

 Distant metastasis

6 (12%)

Par3 expression

 High

10 (20%)

 Intermediate

10 (20%)

 Low

30 (60%)